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M AJOR HISTOCOMPATIBILITY complex (MHC) class 11 (la) antigens 
are thought to act as major factors in initiat-
ing a T-dependent immune response. They are 
either expressed constitutively on the cell sur-
face or variably following activation under 
appropriate influences. ' In allotransplanta-
tion, immunogenicity is determined by the 
presence of these gene products on the grafted 
cells, ie, by the extent of their expression that 
may be manipulated by various protocols. 2-4 
Constitutive expression in the mouse, rat, and 
dog is believed to be restricted to the marrow-
derived macrophages, dendriticlike cells, B 
lymphocytes, and activated T lymphocytes, 
whereas in humans it includes the non-
marrow-derived vascular endothelial cells.s In 
contrast to this widely held view, we recently 
found in rats constitutively expressed class 11 
(I-A) antigens on pancreatic islet vascular 
endothelial and epithelial (3 cells.6 The ques-
tion arose whether this surprising finding 
would also hold for (1) the non-marrow-
derived cells of other tissues, (2) rat strains, 
which so far were not included in our studies, 
and (3) the I-E subregion of the rat RTl 
complex. This study was greatly facilitated by 
the availability of the high-titered anti-I-E 
monoclonal antibody (MoAb) 29Al of our 
own production that we used in comparison 
with MRC-OX17 and MRC-OX6. 
MATERIALS AND METHODS 
Animals 
Male LEW (RTl\ AS (RTl'), F344 (RTl'V'), BN 
(RTl n), DA (RTI IV'), CAP (RTl') and AVN (RTla) 
rats were bred at our department. AUG (RTI') rats 
(RTl') were obtained from OLAC, England; PUG 
(RTI') from Mollegaards Breeding Center, Denmark; 
and LEW.IC (RTl') from Institut Versuchstierkunde, 
Hannover, FRG. All rats were aged 2 to 3 months. 
Islet Isolation 
Islet isolation was performed by collagenase digestion 
according to Lacy and Kostianovsky.7 Only clean, hand-
picked islets were used. 
Tissue Section Preparation 
The animals were killed under ether anesthesia. The 
spleen, thymus, liver, heart, kidney, pancreas and adrenal 
gland were removed immediately, placed into ice-cold 
phosphate-buffered saline, cut into small pieces, snap-
frozen, and stored in N2• Cryostat sections of 8 ILm were 
cut, air-dried on gelatinized slides, fixed in acetone, and 
stored at - 20°C until used. 
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MoAbs 
MRC-OX6 (anti-rat I-A) and MRC-OXI7 (anti-rat 
I-E) were obtained from Camon, Wiesbaden, FRG, as 
ascites fluids and used in dilutions 1:40 to 1:70. 29AI 
(anti-rat I-E) was produced and described by us' and used 
as culture supernatant I: I. Following careful recloning, 
hybridoma cells produced high avidity antibodies only 
during the early culture phase. Therefore, supernatants 
collected in the first 2 weeks are referred to as 29A I-HT 
(high titer), whereas later supernatants are called 29A 1-
l T (Iow titer). Secondary antibodies of standard quality 
were obtained from various companies. 
Histological Techniques 
The procedure for immunofluorescence studies with 
intact islets has been described elsewhere.6 Briefly, islets 
were incubated with the appropriate MoAb in 10-ml 
plastic tubes, transferred onto glass slides (20 islets in 10 
IlL buffer), sealed with a cover slide, and screened 
microscopically for fluorescent cells under a Zeiss ICM 
405. The immunoperoxidase technique was performed 
according to a standard procedure. 
RESULTS 
Immunofluorescence Studies of Intact Islets 
Table I summarizes the results with islets 
of the various rat allotypes after staining with 
the four anti-class 11 MoAbs. When using the 
29AI-HT, all four RTl c allotypes showed a 
significant MHC class 11 (I-E) antigen ex-
pression not only on macrophages, dendritic-
like cells and lymphocytes, but also on 
vascular endothelial and epithelial !3 cells. 
(Evaluation of the relatively weaker antigen 
expression on the non-marrow-derived cells 
was facilitated by the fact that background 
staining in all experiments was definitely neg-
ative). By contrast, I-E antigen expression on 
islet cells of the non-RTl c group was clearly 
limited to the marrow-derived cells. When 
using the 29AI-LT, MRC-OXI7, and MRC-
OX6 MoAbs, islets of both groups showed 
identical patterns, ie, I-E and I-A antigens 
were detectable only on the marrow-derived 
cells. 
Immunoperoxidase Studies of Nonlymphoid 
Tissues (Pancreas, Heart, Liver, Kidney, 
Adrenal Gland) 
The results of the studies with frozen tissue 
sections are summarized in Table 2. As 
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expected from the preceding studies with 
intact islets, the four MoAbs reacted uni-
formly positive with the marrow-derived cells 
in all five tissues investigated and in all rat 
strains, RTIC, or non-RTlc. The specification 
of these cells into cells of the macrophage/ 
dendriticlike group and, occasionally, lym-
phocytes was not intended. 
However, in studying non-marrow-derived 
cells, 29AI-HT clearly differentiated between 
the RTl c and the non-RTl c allotypes in con-
trast to the other MoAbs. In all five tissues, 
cells of the vascular endothelium (including 
venous, arterial, and capillary endothelial 
cells) stained positively for I-E antigens. This 
finding is documented for the sinusoids of the 
liver in Fig ) A. Other non-marrow-derived 
cells that by the use of 29AI-HT were 
detected to express J-E antigens in RTl c tis-
sues are the following: pancreatic islet !3 cells 
(in confirmation of the aforementioned immu-
nofluorescence data) as shown in Fig I C, 
hepatocytes as shown in Fig lA, and medul-
lary epithelial cells of the adrenal gland. It 
may be pointed out that background staining 
of control sections was definitely negative. 
Immunoperoxidase Studies of Lymphoid 
Tissues (Spleen. Thymus) 
The results are given in Table 2. Like the 
nonlymphoid tissues, vascular endothelial 
cells of the various regions within the two 
lymphatic tissues stained positively only with 
the 29AI-HT and only in the RTl c group. In 
addition, cortical epithelial cells of the thymus 
that reacted similarly with 29AI-LT, MRC-
OX)7, and MRC-OX6 in both RTl groups 
showed a clearly stronger staining pattern 
with 29Al-HT in the RTl c group. 
Preliminary Studies With Human Islet 
Tissue 
Of ten crude human islet preparations eight 
were investigated by immunofluorescence for 
a possibly variable DR expression on the 
various cell types within the preparation. 
Marrow-derived macrophages and dendritic-
like cells (including a larger and a smaller 
Table 1. MHC Class 11 Antigen Expression of Various Cells in Intact Islets Using Rat Strains of Different Allotypes (Immunofluorescence Studies) 
Cell Type Within RT1' Group Non-RT1' Group 
MoAbs Isolated Islet CAP AUG PVG LEW.1C LEW AS F344 BN DA AVN 
M0-DC ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ 
29A 1-HT (I-E) LV ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
VE ++ ++ ++ ++ 
{J cells ++1+ ++1+ ++1+ ++1+ 
29A 1-L T (I-E) Mai-DC ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ 
MRC-OX 17 (I-E) LV ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
MRC-OX6 (I-A) VE 
(3 cells 
Cell types: M0-DC, macrophages and dendriticlike cells; LV, Iymphocytes; VE, vascular endothelial cells (venae, arteriae, capillaries); (3 cells, endocrine {J cells. 
Fluorescence grading: + + + +, very strong; + + +, strong; + +, medium; +, weak; (+ I. very weak; -, no detectable fluorescence; N = 200 to 600 clean, hand-picked islets per 
strain per MoAb. 
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Table 2. MHC Class 11 Antigen Expression of Various Cells in Tissue Sections of Different Nonlymphoid and 
Lymphoid Organs Using Rat Strains of Different Allotypes (lmmunoperoxidase Studies) 
ATI'Group Non-RT1' Group 
29A 1-LT 29Al-L T 
MAC-OX17 MAC-OXI7 
Tissue 29A I-HT MAC-OX6 29A I-HT MAC-OX6 
Nonlymphoid 
Pancreas 
Endocrine 
MQ)...OC +++ +++ +++ +++ 
VE ++ 
Epithelial cells ++1+ 
Exocrine 
M~-OC +++ +++ +++ +++ 
VE ++ 
Epithelial cells 
Heart 
M~-OC +++ +++ +++ +++ 
VE ++ 
Myocardial cells 
Liver 
MQ)...OC +++ +++ +++ +++ 
VE ++ 
Hepatocytes +1++ 
Kidney 
M~-OC +++ +++ +++ +++ 
VE ++ 
Tubular epithelial cells 
Adrenal gland 
Cortex 
MQ)...OC +++ +++ +++ +++ 
VE ++ 
Adrenocortical cells 
Medulla 
MQ)...OC +++ +++ ++-r +++ 
VE ++ 
Adrenomedullary cells +1++ 
Lymphoid 
Spleen 
M~-OC +++ +++ +++ +++ 
Reticular cells (germinal center) + + + + 
Reticular cells (PALS) ++ ++ ++ ++ 
Marginal zone (L Y) + + + + 
VE ++ 
Thymus 
MQ)...OC +++ +++ +++ +++ 
Cortical epithelial cells ++ + + + 
Medullary reticular cells +++ +++ +++ +++ 
VE ++ 
Thymocytes 
Cell type: PALS, periarterial lymphatic sheeth. 
Peroxidase staining: + + + +, very strong; + + +, strong; + +, medium; +, weak; (+ l. very weak; -, no detectable 
staining; N ~ 3 experiments per tissue per strain per MoAb. 
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Fig 1. Immunoperoxidase staining of non lymphoid RT1" tissues with anti-MHC class 11 MoAbs. (A) Liver with 
29A 1-HT, original magnification x250 (arrows, positively stained hepatocytes); (B) liver with 29Al-L T, MRC-OXl 7, 
and MRC-OX6 original magnification x250; (C) exocrine and endocrine pancreas with 29Al-HT, original magnifica-
tion X lOO (inset, positively stained endocrine epithelial cells, original magnification x250); (D) exocrine and 
endocrine pancreas with 29A 1 -LT, MRC-OXl 7, and MRC-OX6, original magnification xl 00. 
subtype) expressed MHC class 11 antigens 
uniformly very strongly, whereas non-mar-
row-derived endocrine epithelial cells did not 
express this class of antigens in either one of 
the preparations. However, a variation was 
observed with non-marrow-derived islet vas-
cular endothelial and exocrine epithelial cells: 
In four of eight preparations only a very 
limited amount (\ 0% to 30%) of the total 
capillary net expressed class II antigens 
strongly, whereas in the remaining four of 
eight preparations, this strong expression 
could be detected on 80% to 90% of the 
endothelial cell mass; with regard to exocrine 
epithelial cells, in three of eight preparations 
they definitely expressed class II antigens, 
though weakly; in four of eight preparations 
this expression was reduced to very weak, and 
in one of eight preparations it remained unde-
tectable. These preliminary results with 
human islet preparations show a variably 
determined MHC class 11 expression also in 
human tissue; however, a close correlation of 
this variability with HLA-DR tissue type, sex, 
or age of the islet donor could not be demon-
strated thus far. 
DISCUSSION 
The results of our studies with rats, newly 
obtained from intentionally varied sources, 
indicate a genetically variably determined 
constitutive expression of the MHC class II 
(I-E) antigen on non-marrow-derived cells in 
various rat organs. These findings are depen-
dent on the particular reactivity of 29AI-HT. 
This antibody is clearly of monoclonal origin 
and anti-RTI/I-E, as revealed by compara-
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tive serology, affinity chromatography, and 
immunoprecipi ta tion / gel electrophoresis. 8 
One possible explanation for the drop of anti-
body avidity, which takes place when the 
hybridoma cells are cultured over a long 
period of time, may be seen in chromosomal 
rearrangements.9 The fact that neither high 
concentrations of purified 29AI-LT protein 
nor high antibody concentrations in ascites 
fluid from 29A 1-LT cells were able to react 
demonstrably with the antigen on non-mar-
row-derived cells in RTI C tissues supports this 
hypothesis. 
The question arises whether the low-level 
expression of the I-E determinant that 
remains undetectable by other antibodies is of 
functional relevance in terms of allograft 
immunogenicity. Our preliminary answer to 
this question is yes because of the following 
observations: (1) In MLC-like T lymphocyte 
proliferation assays the stimulator CAP pan-
creatic islets provided reduced stimulation 
upon preincubation with 29AI-LT, but they 
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ceased to stimulate following preincubation 
with 29AI-HT (which, presumably, provides 
additional blockage of the I-E epitopes on 
RTl C vascular endothelial and fJ cells) (manu-
script in preparation). (2) In allografting 
experiments with 29AI-LT (plus comple-
ment)-pretreated islets, CAP (RTlC) grafts 
were more rapidly rejected (3 to 4 days) than 
BN (non-RTI C) grafts (6 to 9 days), which 
presumably do not express I-E on the many 
present endothelial and fJ cells. Both donors do 
not differ significantly from each other in 
class I antigens (manuscript in preparation). 
From the latter consideration it follows that 
for successful transplantation in different 
strain combinations it may be advantageous to 
take the variably determined MHC class 11 
antigen expression into account. This implies 
that better defined manipulation protocols 
can be planned to obtain satisfying grafting 
results. Many problems remain open, not the 
least is the question of an analogue in the 
human, which we are presently looking for. 
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